New Tests

Test Number Test Name

Effective Date 1/8/2019

3001158 Melatonin Quantitative, Serum or Plasma

Effective Date 1/4/2019

3001129 Capillary Malformation-Arteriovenous Malformation 2 (EPHB4) Sequencing
3001132 Capillary Malformation-Arteriovenous Malformation (EPHB4 and RASA1) Sequencing, and (RASA1) Deletion/Duplication

Effective Date 12/11/2018

3001161 FLT3 ITD and TKD Mutation Detection

Effective Date 11/12/2018

3000082 Antinuclear Antibody (ANA) with HEp-2 Substrate, IgG by IFA
3000601 Antinuclear Antibody (ANA) with HEp-2 Substrate, IgG by IFA with Reflex by Pattern
3000876 Aspergillus fumigatus Antibody IgG
3000480 Comprehensive Systemic Sclerosis Panel
3000479 Criteria Systemic Sclerosis Panel
3000537 Eosinophil Cationic Protein (ECP)
3000867 Human Immunodeficiency Virus 1 (HIV-1) by Quantitative NAAT, Plasma
3000870 Human Immunodeficiency Virus 1 (HIV-1) by Quantitative NAAT with Reflex to HIV-1 Genotype by Sequencing
3000871 Human Immunodeficiency Virus 1 (HIV-1) by Quantitative NAAT with Reflex to HIV PhenoSense GT
3000872 Human Immunodeficiency Virus 1 (HIV-1) by Quantitative NAAT, CSF
3000863 Hepatitis B Virus (HBV) by Quantitative NAAT
3000866 Hepatitis B Virus (HBV) by Quantitative NAAT with Reflex to HBV Genotype by Sequencing
3000462 Immature PLT Fraction
3000712 Propafenone Quantitation, Serum or Plasma
2012849 Rapid Mendelian Genes Sequencing Panel, Trio
3000714 Sotalol Quantitation, Serum/Plasma
3000721 Ziprasidone Quantitation, Serum or Plasma

Effective Date 11/6/2018

3001149 Uroplakin II by Immunohistochemistry

Effective Date 11/5/2018

3000394 Malignancy Risk Assessment, Pelvic Mass, OVA1

Effective Date 10/15/2018

3000724 B-Cell Acute Lymphocytic Leukemia (B-ALL) Minimum Residual Disease Detection by Flow Cytometry (COG Protocol)
3000134 Prostate Health Index